<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50">
 <label>50.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Takashita</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Morita</surname>
    <given-names>H</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ogawa</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Nakamura</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Fujisaki</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shirakura</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kuwahara</surname>
    <given-names>T</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kishida</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Watanabe</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Odagiri</surname>
    <given-names>T</given-names>
   </name>
  </person-group>
  <year>2018</year>
  <article-title>Susceptibility of influenza viruses to the novel cap-dependent endonuclease inhibitor baloxavir marboxil</article-title>. 
  <source>Front Microbiol</source>
  <volume>9</volume>:
  <fpage>3026</fpage>. doi:
  <pub-id pub-id-type="doi">10.3389/fmicb.2018.03026</pub-id>.
  <pub-id pub-id-type="pmid">30574137</pub-id>
 </mixed-citation>
</ref>
